Nynex Therapeutics' Seed Round

Nynex Therapeutics raised a round of funding on March 15, 2017.

Nynex Therapeutics is developing breakthrough drugs that inhibit deubiquitinases as a novel mechanism for therapeutic intervention in multiple difficult-to-treat cancers.…

Articles about Nynex Therapeutics' Seed Round: